Browse EX-10 agreements

One Hamden Center

2319 Whitney Avenue, Suite 3B

Hamden, CT 06518

Tel 203 859 6800

Fax 203 949 9048

 

June 25, 2026

 

Troy Ingianni, CPA

 

Dear Troy,

 

We are pleased to confirm our offer of employment for the position of Chief Financial Officer, based in our Hamden, Connecticut office. In this challenging role, reporting directly to John Dillon, Chief Executive Officer, you will serve as a key member of the executive leadership team and be responsible for the Company’s cash management, financial planning and analysis, risk management, and overall financial strategy. You will optimize cash flow, ensure regulatory compliance, and provide strategic financial leadership and actionable insights to support the Company’s continued growth and scalability.

…

THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT

THIS THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), is made as of June 29, 2026 by and between Tenax Therapeutics, Inc., a Delaware corporation, with its principal place of business in North Carolina (the “Company”), and Stuart Rich, MD (the “Executive”). The Company and Executive are sometimes referred to herein each as a “Party” and collectively as the “Parties.”

W I T N E S S E T H:

WHEREAS, the Company and the Executive previously entered into that certain Executive Employment Agreement dated on or about January 15, 2021, as amended on June 12, 2024 and January 6, 2026, whereby the Company employed the Executive as its Chief Medical Officer (the “Employment Agreement”);

WHEREAS, the Company and the Executive wish to amend the Employment Agreement pursuant to this Amendment; and

WHEREAS, the Parties expressly intend that this Amendment shall be a writing intended to be an amendment, modification and/or supplement to the Employment Agreement.

…

FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT

THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), is made as of June 29, 2026 by and between Tenax Therapeutics, Inc., a Delaware corporation, with its principal place of business in North Carolina (the “Company”), and Thomas R. Staab, II (the “Executive”). The Company and Executive are sometimes referred to herein each as a “Party” and collectively as the “Parties.”

W I T N E S S E T H:

WHEREAS, the Company and the Executive previously entered into that certain Executive Employment Agreement dated on or about April 9, 2026, whereby the Company employed the Executive as its Chief Financial Officer (the “Employment Agreement”);

WHEREAS, the Company and the Executive wish to amend the Employment Agreement pursuant to this Amendment; and

WHEREAS, the Parties expressly intend that this Amendment shall be a writing intended to be an amendment, modification and/or supplement to the Employment Agreement.

…

FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT

THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), is made as of June 29, 2026 by and between Tenax Therapeutics, Inc., a Delaware corporation, with its principal place of business in North Carolina (the “Company”), and Christopher Thomas Giordano (the “Executive”). The Company and Executive are sometimes referred to herein each as a “Party” and collectively as the “Parties.”

W I T N E S S E T H:

WHEREAS, the Company and the Executive previously entered into that certain Executive Employment Agreement dated on or about July 6, 2021, whereby the Company employed the Executive as its Chief Executive Officer (the “Employment Agreement”);

WHEREAS, the Company and the Executive wish to amend the Employment Agreement pursuant to this Amendment; and

WHEREAS, the Parties expressly intend that this Amendment shall be a writing intended to be an amendment, modification and/or supplement to the Employment Agreement.

…

AMENDMENT NO. 1 TO NINTH AMENDED AND RESTATED CREDIT AGREEMENT

 

AMENDMENT NO. 1 TO NINTH AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of June 29, 2026, by and among GCI, LLC (the “Borrower”), the Subsidiary Guarantors, Ventures Holdco, LLC, Credit Agricole Corporate and Investment Bank, as administrative agent (in such capacity, the “Administrative Agent”), the 2026 Incremental Term A-1 Lender (as defined below), the 2026 Incremental Term A-2 Lender (as defined below), the 2026 Incremental Revolving Lender (as defined below) and the 2026 Incremental Issuing Bank (as defined below).

 

W I T N E S S E T H :

 

WHEREAS, the Borrower, the Lenders from time to time party thereto and the Administrative Agent, among others, are parties to that certain Ninth Amended and Restated Credit Agreement, dated as of March 25, 2025 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement”);

…

UNITED THERAPEUTICS CORPORATION 2026 STOCK INCENTIVE PLAN

 

(effective June 26, 2026)

  

1.            General

 

(a)            Successor to and Continuation of Prior Plan. This United Therapeutics Corporation 2026 Stock Incentive Plan is intended as the successor to and continuation of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan (the “Prior Plan”). From and after the receipt of shareholder approval of this Plan on June 26, 2026 (the “Effective Date”), no additional awards may be granted under the Prior Plan. All awards granted under the Prior Plan will remain subject to the terms of the Prior Plan.

…

Document

Exhibit 10.1

EXECUTION VERSION

ASSIGNMENT, ASSUMPTION AND TERMINATION AGREEMENT

This ASSIGNMENT, ASSUMPTION AND TERMINATION AGREEMENT (this "Agreement"), dated as of June 25, 2026 is made and entered into by and among MediaAlpha, Inc., a Delaware corporation (the "Purchaser"), and each of Insignia QL Holdings, LLC, a Delaware limited liability company, and Insignia A QL Holdings, LLC, a Delaware limited liability company (each, a "Seller" and collectively, the "Sellers"). Capitalized terms that are used but not defined in this Agreement have the meanings specified in that certain Tax Receivable Agreement, dated as of October 27, 2020 (as amended, the "TRA"), by and among the Purchaser, QL Holdings LLC, the Sellers and certain other parties thereto, as amended by First Amendment to Tax Receivables Agreement, dated as of October 1, 2023, by and among the Purchaser, White Mountains Insurance Group, LTD, Tony Broglio and Tigran Sinanyan.

W I T N E S S E T H:

…

Document

Exhibit 10.1

TWELFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

TWELFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of June 24, 2026, among MERITAGE HOMES CORPORATION, a Maryland corporation (the “Borrower”), MIZUHO BANK, LTD., as assignee from JPMorgan Chase Bank, N.A., as administrative agent on behalf of the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”), and the Lenders party hereto.

RECITALS:

…

Execution Version

$750,000,000

USD Revolving Facility

$250,000,000

Multicurrency Revolving Facility

 

 

CREDIT AGREEMENT

among

MIDERA FOOD PROCESSING, INC., as Company

ALKAR HOLDINGS, INC., as Initial Borrower

CERTAIN OTHER SUBSIDIARIES OF COMPANY

FROM TIME TO TIME PARTY HERETO,

as Other Borrowers,

BANK OF AMERICA, N.A.

as Administrative Agent

and

VARIOUS LENDING INSTITUTIONS

Dated as of June 29, 2026

 

 

BANK OF AMERICA, N.A.,

COOPERATIEVE RABOBANK U.A., NEW YORK BRANCH,

JPMORGAN CHASE BANK, N.A.,

PNC CAPITAL MARKETS LLC and

WELLS FARGO BANK, NATIONAL ASSOCIATION

as Lead Arrangers and Bookrunners

COOPERATIEVE RABOBANK U.A., JPMORGAN CHASE BANK, N.A., PNC BANK, NATIONAL ASSOCIATION and WELLS FARGO BANK, NATIONAL ASSOCIATION

as Syndication Agents

ING BANK N.V., DUBLIN BRANCH, KEYBANK NATIONAL ASSOCIATION

and TD BANK, N.A.

as Co-Documentation Agents

and

BANK OF AMERICA, N.A.,

as Initial Issuing Bank

 

---

…

Execution Version

 

AMENDED & RESTATED EXPENSE SUPPORT AND CONDITIONAL REIMBURSEMENT AGREEMENT

 

This Amended and Restated Expense Support and Conditional Reimbursement Agreement (the “Agreement”) is made this June 29, 2026, and effective as of May 2, 2026 (the “Effective Date”), by and between PennantPark Private Income Fund, a Delaware statutory trust (the “Company”), and PennantPark Private Income Fund Advisers LLC, a Delaware limited liability company (the “Investment Adviser”).

 

WHEREAS, the Company is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “Investment Company Act”);

 

WHEREAS, the Company has retained the Investment Adviser to furnish investment advisory services to the Company on the terms and conditions set forth in the amended and restated investment advisory management agreement, dated October 29, 2025, entered between the Company and the Investment Adviser (the “Investment Advisory Management Agreement”);

…

SHARE LENDING AGREEMENT

 

Dated as of June 24, 2026

 

Among

 

HERTZ GLOBAL HOLDINGS, INC. (“Lender”),

 

And

 

J.P. MORGAN SECURITIES LLC (“Borrower”)

 

This AGREEMENT sets forth the terms and conditions under which Borrower may borrow from Lender shares of Common Stock (as defined below).

 

The parties hereto agree as follows:

 

Section 1. Certain Definitions. The following capitalized terms shall have the following meanings:

 

“Business Day” means a day on which regular trading occurs in the principal trading market for the Common Stock and on which banking institutions in New York City are generally open for business.

 

“Cash” means any coin or currency of the United States as at the time shall be legal tender for payment of public and private debts.

 

“Clearing Organization” means The Depository Trust Company, or, if agreed to by Borrower and Lender, such other securities intermediary at which Borrower and Lender maintain accounts.

…

MUTUAL TERMINATION AGREEMENT

 

June 26, 2026

 

Reference is made to that certain sales agreement, dated as of March 31, 2026 (the “Sales Agreement”), by and between Cheetah Net Supply Chain Service Inc., a Delaware corporation (the “Company”), and AC Sunshine Securities LLC (the “Sales Agent”), relating to the offer and sale from time to time of shares of the Company’s Class A common stock, par value $0.0001 per share, pursuant to the Company’s registration statement on Form S-3, File No. 333-281820, including the prospectus supplement relating to the offering of shares of Class A common stock pursuant to the Sales Agreement. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Sales Agreement

 

As permitted by Section 11(e) of the Sales Agreement and by mutual agreement of the parties, the Company and the Sales Agent hereby agree that the Sales Agreement shall be terminated in its entirety, effective as of the close of business on June 26, 2026 (the “Termination Time”).

…